G70.2 Congenital and developmental myasthenia

ICD-10-CM G70.2: Congenital and developmental myasthenia

ICD-10-CM code G70.2 designates congenital and developmental myasthenia, an active diagnosis classified under myoneural disorders. It identifies conditions present from birth rather than acquired later in life. This code is considered billable for reimbursement when supported by medical evidence. 1 6

Plain-language overview

Code G70.2 identifies congenital and developmental myasthenia, a condition used when the condition is present from birth and not acquired later in life. 6

Congenital myasthenic syndromes are characterized by weak muscles that tire easily, with symptoms beginning shortly after birth or during early childhood and varying from minor weakness to severe disability. 3

What this code represents

The terminology record for G70.2 lists its preferred name as congenital and developmental myasthenia, assigns it active status, and classifies its semantic types as congenital abnormality and disease or syndrome. 1 5

In the ICD-10-CM hierarchy, G70.2 is a narrower concept under the parent category G70, which covers myasthenia gravis and other myoneural disorders, alongside other specified and toxic conditions. 1 4

Documentation considerations

A myasthenia gravis ICD code is used when a patient presents with impaired communication at the myoneural junction, such as fluctuating muscle weakness, and is diagnosed with myasthenic syndromes based on clinical assessments. 6

To increase diagnostic accuracy in one national database study, researchers mitigated the lack of clinical and electrophysiological data by requiring at least three separate G70.2 diagnostic code entries to define a confirmed case. 2

Coverage and utilization context

Myasthenia gravis diagnoses are billable, which allows for reimbursement when properly documented and supported by medical evidence, though the sources do not address specific payer coverage rules. 6

What the sources add

While terminology records define the code hierarchy and semantic type, clinical literature explains that treatment for congenital myasthenic syndromes is often determined by the specific genetic cause of the disorder. 1 3

A retrospective national cohort study utilized the G70.2 code to track 1,315 individuals in an electronic health database, designating the initial entry date as the date of diagnosis for epidemiological research. 2

Sources

1. ICD-10-CM G70.2 terminology record — National Cancer Institute Enterprise Vocabulary Services; accessed 2026-07-27.
2. Epidemiological study of congenital myasthenic syndromes based on national electronic health database of Turkiye — pmc.ncbi.nlm.nih.gov; accessed 2026-07-27.
3. Congenital myasthenic syndromes: MedlinePlus Genetics — medlineplus.gov; accessed 2026-07-27.
4. ICD-10 Version:2019 — icd.who.int; accessed 2026-07-27.
5. EVS Explore — evsexplore.semantics.cancer.gov; accessed 2026-07-27.
6. Myasthenia Gravis ICD-10-CM Codes — carepatron.com; accessed 2026-07-27.